V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Associate Director - CMC Quality Compliance and Inspection Readiness

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • Knowledge of global regulatory requirements and inspection expectations.
  • Experience in multiple modalities is preferred.
  • Strong technical knowledge of inspection management and risk management.
  • Experience with continuous improvement methods such as Six Sigma or Lean.
  • Ability to lead improvement projects and project teams and organize teams and forums.
  • Facilitation, communication, coaching, and influencing skills, with the ability to lead teams.
  • Ability to identify and analyze performance indicators.
  • Bachelor's degree in a scientific discipline, allied health field, or equivalent degree.
  • At least 8 years of relevant experience.

Responsibilities

  • Manage inspection readiness and compliance programs for external operations, working cross-functionally and across the company to help sites achieve and maintain inspection readiness.
  • Identify and drive resolution of issues, gaps, and risks through collaboration with operational areas, assessments, audits, and trend evaluation.
  • Support and oversee inspection execution, including responses and CAPA closure.
  • Integrate across functions, foster collaboration and knowledge sharing, and develop partnerships with external sites.
  • Drive optimization, continuous improvement, and operational excellence to enhance processes.
  • Report inspection readiness status and risks to leadership and governance forums.

Desired Qualifications

  • Experience in multiple modalities.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs